vs

Side-by-side financial comparison of Inspirato Inc (ISPO) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $55.5M, roughly 1.5× Inspirato Inc). Inspirato Inc runs the higher net margin — -8.1% vs -38.1%, a 29.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -19.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -11.4%).

Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ISPO vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.5× larger
PRCT
$83.1M
$55.5M
ISPO
Growing faster (revenue YoY)
PRCT
PRCT
+39.8% gap
PRCT
20.2%
-19.6%
ISPO
Higher net margin
ISPO
ISPO
29.9% more per $
ISPO
-8.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-11.4%
ISPO

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ISPO
ISPO
PRCT
PRCT
Revenue
$55.5M
$83.1M
Net Profit
$-4.5M
$-31.6M
Gross Margin
31.4%
64.9%
Operating Margin
-8.0%
-4.1%
Net Margin
-8.1%
-38.1%
Revenue YoY
-19.6%
20.2%
Net Profit YoY
-204.4%
-27.9%
EPS (diluted)
$-0.36
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPO
ISPO
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$55.5M
$83.3M
Q2 25
$63.1M
$79.2M
Q1 25
$65.9M
$69.2M
Q4 24
$63.1M
$68.2M
Q3 24
$69.1M
$58.4M
Q2 24
$67.4M
$53.4M
Net Profit
ISPO
ISPO
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-4.5M
$-21.4M
Q2 25
$-5.3M
$-19.6M
Q1 25
$1.6M
$-24.7M
Q4 24
$-2.3M
$-18.9M
Q3 24
$4.3M
$-21.0M
Q2 24
$-8.7M
$-25.6M
Gross Margin
ISPO
ISPO
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
31.4%
64.8%
Q2 25
27.5%
65.4%
Q1 25
38.8%
63.9%
Q4 24
34.7%
64.0%
Q3 24
71.5%
63.2%
Q2 24
24.0%
59.0%
Operating Margin
ISPO
ISPO
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-8.0%
-27.8%
Q2 25
-8.3%
-28.0%
Q1 25
2.5%
-39.7%
Q4 24
-3.2%
-28.9%
Q3 24
9.8%
-38.4%
Q2 24
-22.8%
-50.3%
Net Margin
ISPO
ISPO
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-8.1%
-25.7%
Q2 25
-8.4%
-24.7%
Q1 25
2.5%
-35.8%
Q4 24
-3.6%
-27.6%
Q3 24
6.3%
-35.9%
Q2 24
-12.9%
-48.0%
EPS (diluted)
ISPO
ISPO
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.36
$-0.38
Q2 25
$-0.42
$-0.35
Q1 25
$0.12
$-0.45
Q4 24
$0.98
$-0.34
Q3 24
$0.62
$-0.40
Q2 24
$-2.33
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPO
ISPO
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$13.7M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$-134.0M
$347.7M
Total Assets
$228.3M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPO
ISPO
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$13.7M
$294.3M
Q2 25
$16.7M
$302.7M
Q1 25
$16.4M
$316.2M
Q4 24
$21.8M
$333.7M
Q3 24
$13.5M
$196.8M
Q2 24
$18.8M
$214.1M
Total Debt
ISPO
ISPO
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
ISPO
ISPO
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$-134.0M
$380.3M
Q2 25
$-129.7M
$385.8M
Q1 25
$-125.2M
$389.2M
Q4 24
$-129.9M
$402.2M
Q3 24
$-134.6M
$241.2M
Q2 24
$-35.2M
$251.8M
Total Assets
ISPO
ISPO
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$228.3M
$511.5M
Q2 25
$252.6M
$513.1M
Q1 25
$270.1M
$519.4M
Q4 24
$273.9M
$534.0M
Q3 24
$273.3M
$374.1M
Q2 24
$301.7M
$374.4M
Debt / Equity
ISPO
ISPO
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPO
ISPO
PRCT
PRCT
Operating Cash FlowLast quarter
$-2.2M
Free Cash FlowOCF − Capex
$-3.0M
FCF MarginFCF / Revenue
-5.4%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-31.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPO
ISPO
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$-2.2M
$-6.6M
Q2 25
$1.1M
$-15.0M
Q1 25
$-6.6M
$-17.0M
Q4 24
$-15.8M
$-32.4M
Q3 24
$-13.7M
$-18.8M
Q2 24
$-1.8M
$-15.7M
Free Cash Flow
ISPO
ISPO
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-3.0M
$-9.5M
Q2 25
$468.0K
$-17.8M
Q1 25
$-7.5M
$-18.8M
Q4 24
$-21.2M
$-33.6M
Q3 24
$-14.8M
$-19.0M
Q2 24
$-3.7M
$-16.8M
FCF Margin
ISPO
ISPO
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-5.4%
-11.4%
Q2 25
0.7%
-22.5%
Q1 25
-11.4%
-27.2%
Q4 24
-33.7%
-49.2%
Q3 24
-21.5%
-32.6%
Q2 24
-5.5%
-31.4%
Capex Intensity
ISPO
ISPO
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
1.4%
3.4%
Q2 25
1.0%
3.5%
Q1 25
1.3%
2.7%
Q4 24
8.7%
1.7%
Q3 24
1.6%
0.4%
Q2 24
2.8%
2.0%
Cash Conversion
ISPO
ISPO
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
-4.09×
Q4 24
Q3 24
-3.16×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISPO
ISPO

Residence And Hotel Travel$25.9M47%
Subscription$19.4M35%
Experiences And Bespoke Travel$8.0M14%
Rewards And Other Revenue$2.3M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons